{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-027839","form_type":"8-K","ticker":"MED","cik":"0000910329","company_name":"MEDIFAST INC","filed_at":"2023-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.987747+00:00","generated_at":"2026-06-12T05:26:12.596317+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Medifast Q2 revenue falls 34.7% to $296.2M; diluted EPS $2.77 vs $3.42","bullets":["Revenue $296.2M (-34.7%); net income $30.3M, EPS $2.77 vs $39.1M, $3.42 prior.","Active earning OPTA VIA coaches down 21.9% to 53,100; revenue per coach $5,578.","Q3 2023 guidance: revenue $220-$240M, diluted EPS $0.71-$1.32, tax rate 23-25%.","Cash $147.4M, no debt; quarterly dividend of $1.65 per share declared.","CEO cites economic headwinds, cost initiatives; new OPTA VIA ACTIVE line launched."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-027839","json":"https://secwatch.observer/filing/0001628280-23-027839.json","markdown":"https://secwatch.observer/filing/0001628280-23-027839.md","text":"https://secwatch.observer/filing/0001628280-23-027839.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/0001628280-23-027839-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/med-20230807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T05:26:12.596317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"65e87aa08a5492f34e80eedb05208bcac269ecf9","claim":"MEDIFAST INC reported second quarter ended June 30, 2023 results: revenue $296.2 million, net income $30.3 million, EPS $2.77 per diluted share.","evidence_excerpt":"known for its habit-based and Coach-guided lifestyle solution, OPTA VIA® , today reported results for the second quarter ended June 30, 2023 . Second Quarter 2023 • Revenue of $296.2 million, with revenue per active earning coach of $5,578 • Independent active earning OPTA VIA Coaches of 53,100 • Net income of $30.3 million • Earnings per diluted share (\"EPS) of","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/0001628280-23-027839-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"second quarter ended June 30, 2023"},{"label":"Revenue","value":"$296.2 million"},{"label":"Net income","value":"$30.3 million"},{"label":"EPS","value":"$2.77 per diluted share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"dd000abdb264df012d4273fbe0cffc21a5502aaf","claim":"MEDIFAST INC reported third quarter 2023 results: revenue $220 million to $240 million, EPS $0.71 to $1.32. Guidance initiated.","evidence_excerpt":"The Company expects third quarter 2023 revenue to be in the range of $220 million to $240 million and third quarter 2023 diluted EPS to be in the range of $0.71 to $1.32","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/910329/000162828023027839/0001628280-23-027839-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter 2023"},{"label":"Revenue","value":"$220 million to $240 million"},{"label":"EPS","value":"$0.71 to $1.32"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}